Indicators for Gleevec nonadherence were cognitive functioning, global health status score, social support, gender and others ...

(RTTNews) - British drug maker GSK plc (GSK.L, GSK) Monday announced that it has signed an agreement to acquire IDRx, a Boston-based, clinical-stage biopharmaceutical company, for up to $1.15 billion ...

In a deal worth up to $1.15 billion, GSK is acquiring precision medicine biotech IDRx and its phase 3-ready gastrointestinal ...

Dr. Ngozi Ezike, the face of Illinois' response to the COVID-19 pandemic, admitted to an ethics violation for taking the CEO ...

The first major deal of JPM 2025 will give GSK a promising small molecule drug for gastrointestinal stromal tumors.

Under the agreement, GSK will pay $1billion upfront to acquire the Massachussetts-based firm, followed by up to $150million ...

British pharmaceutical company GSK on Monday said it had agreed to buy a US company that specialises in the treatment of rare gastrointestinal cancer GIST.

To address this, Science X is excited to introduce a new feature: The GIST—short for "Get Instant Summarized Text." The GIST provides concise, AI-generated summaries of each article, offering readers ...

Gist (6-0, 197) is currently ranked a three-star, the No. 2,029 overall recruit in the 2025 On3 Industry Rankings. He is also ranked the No. 146 running back and the No. 55 recruit in Illinois.